The ACCOuNT Consortium

A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans

Paula N. Friedman, Mohammed Shaazuddin, Li Gong, Robert L. Grossman, Arthur F. Harralson, Teri E. Klein, Norman H. Lee, Doriane C. Miller, Edith A. Nutescu, Travis J. O'Brien, Peter H. O'Donnell, Kevin John O'Leary, Matthew Tuck, David O. Meltzer, Minoli Perera*

*Corresponding author for this work

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The majority of pharmacogenomic (PGx) studies have been conducted on European ancestry populations, thereby excluding minority populations and impeding the discovery and translation of African American–specific genetic variation into precision medicine. Without accounting for variants found in African Americans, clinical recommendations based solely on genetic biomarkers found in European populations could result in misclassification of drug response in African American patients. To address these challenges, we formed the Transdisciplinary Collaborative Center (TCC), African American Cardiovascular Pharmacogenetic Consortium (ACCOuNT), to discover novel genetic variants in African Americans related to clinically actionable cardiovascular phenotypes and to incorporate African American–specific sequence variations into clinical recommendations at the point of care. The TCC consists of two research projects focused on discovery and translation of genetic findings and four cores that support the projects. In addition, the largest repository of PGx information on African Americans is being established as well as lasting infrastructure that can be utilized to spur continued research in this understudied population.

Original languageEnglish (US)
Pages (from-to)209-217
Number of pages9
JournalClinical and Translational Science
Volume12
Issue number3
DOIs
StatePublished - May 1 2019

Fingerprint

Precision Medicine
Pharmacogenetics
African Americans
Medicine
Biomarkers
Population
Point-of-Care Systems
Pharmaceutical Preparations
Protein Biosynthesis
Research
Phenotype

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Friedman, Paula N. ; Shaazuddin, Mohammed ; Gong, Li ; Grossman, Robert L. ; Harralson, Arthur F. ; Klein, Teri E. ; Lee, Norman H. ; Miller, Doriane C. ; Nutescu, Edith A. ; O'Brien, Travis J. ; O'Donnell, Peter H. ; O'Leary, Kevin John ; Tuck, Matthew ; Meltzer, David O. ; Perera, Minoli. / The ACCOuNT Consortium : A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans. In: Clinical and Translational Science. 2019 ; Vol. 12, No. 3. pp. 209-217.
@article{635c945c7fc149d3886626c29722773d,
title = "The ACCOuNT Consortium: A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans",
abstract = "The majority of pharmacogenomic (PGx) studies have been conducted on European ancestry populations, thereby excluding minority populations and impeding the discovery and translation of African American–specific genetic variation into precision medicine. Without accounting for variants found in African Americans, clinical recommendations based solely on genetic biomarkers found in European populations could result in misclassification of drug response in African American patients. To address these challenges, we formed the Transdisciplinary Collaborative Center (TCC), African American Cardiovascular Pharmacogenetic Consortium (ACCOuNT), to discover novel genetic variants in African Americans related to clinically actionable cardiovascular phenotypes and to incorporate African American–specific sequence variations into clinical recommendations at the point of care. The TCC consists of two research projects focused on discovery and translation of genetic findings and four cores that support the projects. In addition, the largest repository of PGx information on African Americans is being established as well as lasting infrastructure that can be utilized to spur continued research in this understudied population.",
author = "Friedman, {Paula N.} and Mohammed Shaazuddin and Li Gong and Grossman, {Robert L.} and Harralson, {Arthur F.} and Klein, {Teri E.} and Lee, {Norman H.} and Miller, {Doriane C.} and Nutescu, {Edith A.} and O'Brien, {Travis J.} and O'Donnell, {Peter H.} and O'Leary, {Kevin John} and Matthew Tuck and Meltzer, {David O.} and Minoli Perera",
year = "2019",
month = "5",
day = "1",
doi = "10.1111/cts.12608",
language = "English (US)",
volume = "12",
pages = "209--217",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "3",

}

Friedman, PN, Shaazuddin, M, Gong, L, Grossman, RL, Harralson, AF, Klein, TE, Lee, NH, Miller, DC, Nutescu, EA, O'Brien, TJ, O'Donnell, PH, O'Leary, KJ, Tuck, M, Meltzer, DO & Perera, M 2019, 'The ACCOuNT Consortium: A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans', Clinical and Translational Science, vol. 12, no. 3, pp. 209-217. https://doi.org/10.1111/cts.12608

The ACCOuNT Consortium : A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans. / Friedman, Paula N.; Shaazuddin, Mohammed; Gong, Li; Grossman, Robert L.; Harralson, Arthur F.; Klein, Teri E.; Lee, Norman H.; Miller, Doriane C.; Nutescu, Edith A.; O'Brien, Travis J.; O'Donnell, Peter H.; O'Leary, Kevin John; Tuck, Matthew; Meltzer, David O.; Perera, Minoli.

In: Clinical and Translational Science, Vol. 12, No. 3, 01.05.2019, p. 209-217.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The ACCOuNT Consortium

T2 - A Model for the Discovery, Translation, and Implementation of Precision Medicine in African Americans

AU - Friedman, Paula N.

AU - Shaazuddin, Mohammed

AU - Gong, Li

AU - Grossman, Robert L.

AU - Harralson, Arthur F.

AU - Klein, Teri E.

AU - Lee, Norman H.

AU - Miller, Doriane C.

AU - Nutescu, Edith A.

AU - O'Brien, Travis J.

AU - O'Donnell, Peter H.

AU - O'Leary, Kevin John

AU - Tuck, Matthew

AU - Meltzer, David O.

AU - Perera, Minoli

PY - 2019/5/1

Y1 - 2019/5/1

N2 - The majority of pharmacogenomic (PGx) studies have been conducted on European ancestry populations, thereby excluding minority populations and impeding the discovery and translation of African American–specific genetic variation into precision medicine. Without accounting for variants found in African Americans, clinical recommendations based solely on genetic biomarkers found in European populations could result in misclassification of drug response in African American patients. To address these challenges, we formed the Transdisciplinary Collaborative Center (TCC), African American Cardiovascular Pharmacogenetic Consortium (ACCOuNT), to discover novel genetic variants in African Americans related to clinically actionable cardiovascular phenotypes and to incorporate African American–specific sequence variations into clinical recommendations at the point of care. The TCC consists of two research projects focused on discovery and translation of genetic findings and four cores that support the projects. In addition, the largest repository of PGx information on African Americans is being established as well as lasting infrastructure that can be utilized to spur continued research in this understudied population.

AB - The majority of pharmacogenomic (PGx) studies have been conducted on European ancestry populations, thereby excluding minority populations and impeding the discovery and translation of African American–specific genetic variation into precision medicine. Without accounting for variants found in African Americans, clinical recommendations based solely on genetic biomarkers found in European populations could result in misclassification of drug response in African American patients. To address these challenges, we formed the Transdisciplinary Collaborative Center (TCC), African American Cardiovascular Pharmacogenetic Consortium (ACCOuNT), to discover novel genetic variants in African Americans related to clinically actionable cardiovascular phenotypes and to incorporate African American–specific sequence variations into clinical recommendations at the point of care. The TCC consists of two research projects focused on discovery and translation of genetic findings and four cores that support the projects. In addition, the largest repository of PGx information on African Americans is being established as well as lasting infrastructure that can be utilized to spur continued research in this understudied population.

UR - http://www.scopus.com/inward/record.url?scp=85061457655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061457655&partnerID=8YFLogxK

U2 - 10.1111/cts.12608

DO - 10.1111/cts.12608

M3 - Review article

VL - 12

SP - 209

EP - 217

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 3

ER -